Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Vistagen Therapeutics, Inc. (EXCA)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vistagen Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Vistagen Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is EXCA. The reporting company's CIK number is 1411685.
The total value of stock buying since 2005 is $25,286.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $182,273.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-03-14||Saxe Jon S||Buy||7,920||1.27||10,090|
|2019-03-13||Snodgrass H. Ralph (PRES./CHIEF SCIENTIFIC OFFICER)||Option Ex||2,500||1.50||3,750|
|2019-03-13||Saxe Jon S||Buy||12,080||1.26||15,196|
|2019-01-29||Saxe Jon S||Option Ex||1,375||1.50||2,062|
|2019-01-14||Singh Shawn (CHIEF EXECUTIVE OFFICER)||Option Ex||25,375||1.50||38,062|
|2017-05-31||Gin Jerry B||Buy||100,000||.00||0|
|2013-10-15||Singh Shawn (CHIEF EXECUTIVE OFFICER)||Option Ex||10,000||.64||6,400|
|2013-06-27||Singh Shawn (CHIEF EXECUTIVE OFFICER)||Option Ex||50,000||.64||32,000|
|2011-12-20||Snodgrass H. Ralph (PRES./CHIEF SCIENTIFIC OFFICER)||Option Ex||113,636||.88||99,999|
|2011-05-09||Jones Stephanie (PRESIDENT)||Sale||4,982,103||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises of EXCA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vistagen Therapeutics, Inc. (symbol EXCA, CIK number 1411685) see the Securities and Exchange Commission (SEC) website.